Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
The American Journal of Cardiology
|
December 28, 2004
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
Peter H Jones, Michael H Davidson
Current Atherosclerosis Reports
|
February 4, 2006
Effective use of combination lipid therapy
Abu R Vasudevan, Peter H Jones
Current Cardiology Reports
|
November 1, 2005
Effective use of combination lipid therapy
Abu R Vasudevan, Peter H Jones
Clinical Drug Investigation
|
September 12, 2008
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet
Michael H Davidson, Peter H Jones
Current Atherosclerosis Reports
|
April 18, 2008
Adjunctive interventions in myocardial infarction: the role of statin therapy
Peter H Jones, John A Farmer
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
April 6, 2016
Closing The Gap: Improving Trauma Care On The Ukrainian Battlefield
Stephen K Stacey, Peter H Jones
Current Atherosclerosis Reports
|
August 13, 2003
Toxicity of antilipidemic agents: facts and fictions
Antonios M Xydakis, Peter H Jones
Vascular Health and Risk Management
|
February 27, 2007
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H Jones
Current Atherosclerosis Reports
|
December 16, 2006
Statin therapy: is the percent reduction or the attained low-density lipoprotein cholesterol level more important?
Tracie C Collins, Peter H Jones
Journal of the American Heart Association
|
January 15, 2013
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis
Peter H Jones, Radhika Nair, Kamlesh M Thakker
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
The American Journal of Cardiology
|
December 28, 2004
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
Peter H Jones, Michael H Davidson
Current Atherosclerosis Reports
|
February 4, 2006
Effective use of combination lipid therapy
Abu R Vasudevan, Peter H Jones
Current Cardiology Reports
|
November 1, 2005
Effective use of combination lipid therapy
Abu R Vasudevan, Peter H Jones
Clinical Drug Investigation
|
September 12, 2008
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet
Michael H Davidson, Peter H Jones
Current Atherosclerosis Reports
|
April 18, 2008
Adjunctive interventions in myocardial infarction: the role of statin therapy
Peter H Jones, John A Farmer
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
April 6, 2016
Closing The Gap: Improving Trauma Care On The Ukrainian Battlefield
Stephen K Stacey, Peter H Jones
Current Atherosclerosis Reports
|
August 13, 2003
Toxicity of antilipidemic agents: facts and fictions
Antonios M Xydakis, Peter H Jones
Vascular Health and Risk Management
|
February 27, 2007
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H Jones
Current Atherosclerosis Reports
|
December 16, 2006
Statin therapy: is the percent reduction or the attained low-density lipoprotein cholesterol level more important?
Tracie C Collins, Peter H Jones
Journal of the American Heart Association
|
January 15, 2013
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis
Peter H Jones, Radhika Nair, Kamlesh M Thakker
Page
of 11